Emily Reichwald - Dr Martens G Sec
| DOCMF Stock | USD 0.72 0.02 2.86% |
Insider
Emily Reichwald is G Sec of Dr Martens plc
| Phone | 44 12 1415 7047 |
| Web | https://www.drmartensplc.com |
Dr Martens Management Efficiency
The company has return on total asset (ROA) of 0.1634 % which means that it generated a profit of $0.1634 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6446 %, meaning that it generated $0.6446 on every $100 dollars invested by stockholders. Dr Martens' management efficiency ratios could be used to measure how well Dr Martens manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jennifer Olsen | Caleres | N/A | |
| Bruce Thorn | Caleres | N/A | |
| Mark Dean | Rocky Brands | N/A | |
| Mary Turner | Designer Brands | 66 | |
| Thomas Burke | Caleres | 56 | |
| William Combs | Weyco Group | N/A | |
| John Kalinich | Deckers Outdoor | 56 | |
| Keith Duplain | Caleres | N/A | |
| Johanna Nielsen | Nike Inc | 46 | |
| Thomas Garcia | Deckers Outdoor | 51 | |
| Charles Ross | American Rebel Holdings | 58 | |
| Wim Schuren | On Holding | N/A | |
| Rick Graham | Skechers USA | N/A | |
| Robert Hanley | Weyco Group | 37 | |
| Angela Ogbechie | Deckers Outdoor | 45 | |
| Margaret Standing | Designer Brands | N/A | |
| Marc Maurer | On Holding | 42 | |
| W McGinnis | Caleres | 72 | |
| David Allemann | On Holding | 53 | |
| Alex Griffin | On Holding | N/A | |
| Scott Jenkins | Rocky Brands | N/A | |
Management Performance
| Return On Equity | 0.64 | |||
| Return On Asset | 0.16 |
Dr Martens plc Leadership Team
Elected by the shareholders, the Dr Martens' board of directors comprises two types of representatives: Dr Martens inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DOCMF. The board's role is to monitor Dr Martens' management team and ensure that shareholders' interests are well served. Dr Martens' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Martens' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Meg Johnson, Chief Officer | ||
| Sue Gannon, Chief Officer | ||
| Emily Reichwald, G Sec | ||
| Lorenzo Moretti, Pres EMEA | ||
| Jon Mortimore, CFO Director | ||
| Kenneth Wilson, CEO Director | ||
| Sean ONeill, Chief Officer | ||
| Ronald Garricks, Chief Officer | ||
| Derek Chan, Pres APAC | ||
| Geert Peeters, Chief Officer |
DOCMF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Dr Martens a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.64 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 2.75 B | |||
| Shares Outstanding | 1 B | |||
| Shares Owned By Insiders | 3.85 % | |||
| Shares Owned By Institutions | 69.40 % | |||
| Price To Earning | 33.56 X | |||
| Price To Book | 5.71 X |
Currently Active Assets on Macroaxis
Other Information on Investing in DOCMF Pink Sheet
Dr Martens financial ratios help investors to determine whether DOCMF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOCMF with respect to the benefits of owning Dr Martens security.